Literature DB >> 15151378

5-Lipoxygenase activating protein (ALOX5AP): association with cardiovascular infarction and stroke.

Edna Ben-Asher1, Doron Lancet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15151378

Source DB:  PubMed          Journal:  Isr Med Assoc J            Impact factor:   0.892


× No keyword cloud information.
  3 in total

1.  Exploring N(1)-p-fluorobenzyl-cymserine as an inhibitor of 5-lipoxygenase as a candidate for type 2 diabetes and neurodegenerative disorder treatment.

Authors:  Qurrat ul Ain; Nigel H Greig; Muhammad S Nawaz; Sajid Rashid; Mohammad A Kamal
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

Review 2.  Identifying novel genes for atherosclerosis through mouse-human comparative genetics.

Authors:  Xiaosong Wang; Naoki Ishimori; Ron Korstanje; Jarod Rollins; Beverly Paigen
Journal:  Am J Hum Genet       Date:  2005-05-19       Impact factor: 11.025

3.  Inhibition of NF-kappaB activation by 5-lipoxygenase inhibitors protects brain against injury in a rat model of focal cerebral ischemia.

Authors:  Manu Jatana; Shailendra Giri; Mubeen A Ansari; Chinnasamy Elango; Avtar K Singh; Inderjit Singh; Mushfiquddin Khan
Journal:  J Neuroinflammation       Date:  2006-05-11       Impact factor: 8.322
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.